JPMorgan Chase & Co’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9M | Sell |
|
|||||
|
2025
Q1 | $75.5M | Buy |
|
|||||
|
2024
Q4 | $86.8M | Buy |
|
|||||
|
2024
Q3 | $134M | Sell |
|
|||||
|
2024
Q2 | $119M | Buy |
|
|||||
|
2024
Q1 | $85.3M | Buy |
|
|||||
|
2023
Q4 | $10.6M | Buy |
|
|||||
|
2023
Q3 | $6.17M | Buy |
|
|||||
|
2023
Q2 | $8.86M | Buy |
|
|||||
|
2023
Q1 | $43.7K | Buy |
|
|||||
|
2022
Q4 | $4K | Sell |
|
|||||
|
2022
Q3 | $80K | Sell |
|
|||||
|
2022
Q2 | $134K | Buy |
|
|||||
|
2022
Q1 | $99K | Buy |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q3 | $164K | Sell |
|
|||||
|
2021
Q2 | $160K | Sell |
|
|||||
|
2021
Q1 | $251K | Buy |
|
|||||
|
2020
Q4 | $167K | Buy |
|
|||||
|
2020
Q3 | $145K | Buy |
|
|||||
|
2020
Q2 | $159K | Buy |
|
|||||
|
2020
Q1 | $101K | Buy |
|
|||||
|
2019
Q4 | $172K | Hold |
|
|||||
|
2019
Q3 | $147K | Buy |
|
|||||
|
2019
Q2 | $149K | Buy |
|
|||||
|
2019
Q1 | $148K | Sell |
|
|||||
|
2018
Q4 | $117K | Buy |
|
|||||
|
2018
Q3 | $209K | Buy |
|
|||||
|
2018
Q2 | $84K | Buy |
|